ICA-121431 blocks sodium channels, affecting the action potential propagation in neurons and muscle cells, crucial for neurological and muscular function. It targets hNav1.1, hNav1.3, hNav1.4, hNav1.5, hNav1.6, and hNav1.8.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.